GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Ending Cash Position

Theratechnologies (Theratechnologies) Ending Cash Position : $32.24 Mil (As of Feb. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Theratechnologies Ending Cash Position?

Theratechnologies's Ending Cash Position for the quarter that ended in Feb. 2024 was $32.24 Mil.

Theratechnologies's quarterly Ending Cash Position increased from Aug. 2023 ($14.97 Mil) to Nov. 2023 ($34.10 Mil) but then declined from Nov. 2023 ($34.10 Mil) to Feb. 2024 ($32.24 Mil).

Theratechnologies's annual Ending Cash Position increased from Nov. 2021 ($20.40 Mil) to Nov. 2022 ($23.86 Mil) and increased from Nov. 2022 ($23.86 Mil) to Nov. 2023 ($34.10 Mil).

Theratechnologies Ending Cash Position Historical Data

The historical data trend for Theratechnologies's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Ending Cash Position Chart

Theratechnologies Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.66 12.74 20.40 23.86 34.10

Theratechnologies Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.02 16.96 14.97 34.10 32.24

Theratechnologies Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Theratechnologies's Ending Cash Position for the fiscal year that ended in Nov. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=23.856+10.241
=34.10

Theratechnologies's Ending Cash Position for the quarter that ended in Feb. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=34.097+-1.857
=32.24

Theratechnologies Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Theratechnologies (Theratechnologies) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Ending Cash Position
Comparable Companies
TSX:SVA TSXV:MIR XCNQ:METX TSXV:ARCH XCNQ:DTC TSX:MSCL TSX:ONC XCNQ:ACOG TSX:HBP TSX:MBX OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
TQ80:Germany TH:Canada
Address
2015, rue Peel, 11e etage, Montreal, QC, CAN, H3A 1T8
Website
https://www.theratech.com
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.